03a14739842c65f86909baf81399ea1ea583eda3b15e8366b0d1ddda851b09e0

0480bfde5e1deea104ee6cb5ab056b0140f3479480b6f8d6a6e46c717b0bbbe4

77d6565fac9407b32148f1467cedce636c1eb7715d4b9a7e1535935dc540ec98

U.S. Retail Pharmacy

International

- Germany

- United Kingdom

- Other

U.S. Healthcare

Walgreens Health

Corporate and Other

Pharmaceutical Wholesale

Eliminations

Total Revenue

de679edf4d574f3d2a599237d050c536388682a250c6b9b1eceff9b47d9e2ed3

- Pharmacy

- Retail

- Wholesale

8ecc39143c2460fb65c6ec19cbcb846218c1a724f8e44f9ff33a86182b123363

Sales (USD, millions)

Cost of Sales (USD, millions)

Gross Profit (USD, millions)

Selling, General and Administrative Expenses (USD, millions)

Impairment of Goodwill (USD, millions)

Equity Earnings in Cencora (USD, millions)

Operating (Loss) Income (USD, millions)

Other Income (Expense), Net (USD, millions)

(Loss) Earnings Before Interest and Income Tax (Benefit) Provision (USD, millions)

Interest Expense, Net (USD, millions)

(Loss) Earnings Before Income Tax (Benefit) Provision (USD, millions)

Income Tax (Benefit) Provision (USD, millions)

Post-tax Earnings from Other Equity Method Investments (USD, millions)

Net (Loss) Earnings (USD, millions)

Net Loss Attributable to Non-controlling Interests (USD, millions)

Net (Loss) Earnings Attributable to Walgreens Boots Alliance, Inc. (USD, millions)

Basic Net (Loss) Earnings per Common Share (USD)

Diluted Net (Loss) Earnings per Common Share (USD)

Adjusted Operating Income (Non-GAAP measure) (USD, millions)

Adjusted Net Earnings Attributable to Walgreens Boots Alliance, Inc. (Non-GAAP measure) (USD, millions)

Adjusted Diluted Net Earnings per Common Share (Non-GAAP measure) (USD)

eba2ebb00b56446ac8ac3c3a67226b5e914afcd860b6d4553ad6bb2256df96ab

7278f996f8da5ed6f4ca9554d283932bc145e7b7301ccbe24865a646d883d773

Net cash used for operating activities (USD, millions)

Net cash provided by operating activities (USD, millions)

Net cash (used for) provided by operating activities (USD, millions)

Net cash provided by (used for) investing activities (USD, millions)

Net cash provided by (used for) financing activities (USD, millions)

Net cash used for financing activities (USD, millions)

Net cash (used for) provided by financing activities (USD, millions)

Effect of exchange rate changes on cash, cash equivalents and restricted cash (USD, millions)

Net decrease in cash, cash equivalents and restricted cash (USD, millions)

Net increase (decrease) in cash, cash equivalents, marketable securities and restricted cash (USD, millions)

Additions to property, plant and equipment (USD, millions)

Proceeds from sale-leaseback transactions (USD, millions)

Proceeds from sale of other assets (USD, millions)

Business, investment and asset acquisitions, net of cash acquired (USD, millions)

Other cash flow from investing activities (USD, millions)

Net change in short-term debt with maturities of 3 months or less (USD, millions)

Proceeds from debt (USD, millions)

Payments of debt (USD, millions)

Treasury stock purchases (USD, millions)

Cash dividends paid (USD, millions)

Other cash flow from financing activities (USD, millions)

Cash, cash equivalents and restricted cash at beginning of period (USD, millions)

Cash, cash equivalents, marketable securities and restricted cash at beginning of period (USD, millions)

Cash, cash equivalents and restricted cash at end of period (USD, millions)

Cash, cash equivalents, marketable securities and restricted cash at end of period (USD, millions)

c3cb1cf9294734167ffd32c5bed0dffbc44861482fe77434ef0a417b37a2eb11

Walgreens Boots Alliance Inc (WBA)

Financials